Kenji Tamura
- Oncology top 0.2%
- Molecular Biology top 2%
- Pulmonary and Respiratory Medicine top 0.5%
- Cancer Research top 0.5%
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Co-authors
- Kan YonemoriYasuhiro FujiwaraMasahiro FukuokaMakiko OnoChikako ShimizuTakahiro OchiyaJackie D. WoodHitoshi Tsuda
- Topics
- HER2/EGFR in Cancer Research (75 papers)Lung Cancer Treatments and Mutations (41 papers)Cancer Treatment and Pharmacology (36 papers)
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Kenji Tamura
376 papers receiving 11.7k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Oncology 6.5k
- Molecular Biology 3.5k
- Pulmonary and Respiratory Medicine 3.3k
- Cancer Research 2.5k
- Radiology, Nuclear Medicine and Imaging 1.7k
Countries citing papers authored by Kenji Tamura
This map shows the geographic impact of Kenji Tamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Tamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Tamura more than expected).
Fields of papers citing papers by Kenji Tamura
This network shows the impact of papers produced by Kenji Tamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Tamura. The network helps show where Kenji Tamura may publish in the future.
Co-authorship network of co-authors of Kenji Tamura
This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Tamura. A scholar is included among the top collaborators of Kenji Tamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Tamura. Kenji Tamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 13 | |
| 3 | 1 | |
| 4 | 24 | |
| 5 | 19 | |
| 6 | 3 | |
| 7 | 7 | |
| 8 | 8 | |
| 9 | Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 studybreakdown → | 258 |
| 10 | 47 | |
| 11 | 23 | |
| 12 | 2 | |
| 13 | 55 | |
| 14 | 36 | |
| 15 | 20 | |
| 16 | 54 | |
| 17 | Chemotherapy: Phase Two progress and future perspectives | 1 |
| 18 | PHOTODEGRADATION OF RHODAMINE B IN AQUEOUS SUSPENSION OF SYNTHETIC ZN-SUBSTITUTED PHYLLOSILICATES | 0 |
| 19 | Physico-chemical properties and their variation of amazonian dark earths distributed in middle Amazon basin, Brazil | 1 |
| 20 | Survivin inhibition by si-RNA induces apoptosis and increases sensitivity to adriamycin in human lung cancer cells with p53 mutation | 12 |
About Kenji Tamura
Kenji Tamura is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 387 papers that have together received 11.9k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (75 papers), Lung Cancer Treatments and Mutations (41 papers) and Cancer Treatment and Pharmacology (36 papers). The work is most often cited by research in Oncology (6.5k citations), Cancer Research (2.5k citations) and Pulmonary and Respiratory Medicine (3.3k citations). Kenji Tamura has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Kan Yonemori, Yasuhiro Fujiwara, Masahiro Fukuoka, Makiko Ono, Chikako Shimizu, Takahiro Ochiya, Jackie D. Wood, Hitoshi Tsuda, Toshihiko Doi and Yusuke Yoshioka. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.